Subscribe To
Medtronic's (mdt) cryoablation catheters get fda expanded nod
Medtronic's (MDT) cardiac Cryoablation is the only ablation catheter approved to treat pediatric AVNRT....
February 22, 2022, 9:14 am
Biovaxys says studies on bvx-0320, its haptenized sars-cov-2 s-spike protein vaccine, suggest superior cardiac safety
BioVaxys Technology Corp has revealed that studies on BVX-0320, its haptenized SARS-CoV-2 s-spike protein vaccine candidate, demonstrated that the va...
February 16, 2022, 9:48 am
Biovaxys says studies on bvx-0320, its haptenized sars-cov-2 s-spike protein vaccine, suggest superior cardiac safety
BioVaxys Technology Corp has revealed that studies on BVX-0320, its haptenized SARS-CoV-2 s-spike protein vaccine candidate, demonstrated that the va...
February 16, 2022, 9:48 am
Biovaxys says studies on bvx-0320, its haptenized sars-cov-2 s-spike protein vaccine, suggest superior cardiac safety
BioVaxys Technology Corp has revealed that studies on BVX-0320, its haptenized SARS-CoV-2 s-spike protein vaccine candidate, demonstrated that the va...
February 16, 2022, 9:48 am
Why cardinal health is a sound buy in this crazy market
Why cardinal Health Is A Sound Buy In This Crazy Market...
February 15, 2022, 10:10 pm
Why cardinal health is a sound buy in this crazy market
Why cardinal Health Is A Sound Buy In This Crazy Market...
February 15, 2022, 10:10 pm
Why cardinal health is a sound buy in this crazy market
Why cardinal Health Is A Sound Buy In This Crazy Market...
February 15, 2022, 10:10 pm
Moleculin biotech annamycin doublet therapy shows 68% overall survival in animal study
Moleculin Biotech Inc (NASDAQ: MBRX) has announced preliminary results supporting the successful conclusion of its second Phase 1 trial in Poland, ...
February 14, 2022, 2:10 pm
Moleculin biotech annamycin doublet therapy shows 68% overall survival in animal study
Moleculin Biotech Inc (NASDAQ: MBRX) has announced preliminary results supporting the successful conclusion of its second Phase 1 trial in Poland, ...
February 14, 2022, 2:10 pm
Moleculin biotech annamycin doublet therapy shows 68% overall survival in animal study
Moleculin Biotech Inc (NASDAQ: MBRX) has announced preliminary results supporting the successful conclusion of its second Phase 1 trial in Poland, ...
February 14, 2022, 2:10 pm
Safety board recommends biocardia's heart failure cell therapy to continue unchanged
The independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for Biocardi...
February 14, 2022, 10:29 am
Safety board recommends biocardia's heart failure cell therapy to continue unchanged
The independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for Biocardi...
February 14, 2022, 10:29 am
Safety board recommends biocardia's heart failure cell therapy to continue unchanged
The independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for Biocardi...
February 14, 2022, 10:29 am
Silence therapeutics posts first human data for cardiovascular candidate
Silence Therapeutics plc SLN showed that its RNAi technology could reduce a patient's lp(a) levels by 98% at a high dose. Get the Inside Access Trad...
February 9, 2022, 3:35 pm
Silence therapeutics posts first human data for cardiovascular candidate
Silence Therapeutics plc SLN showed that its RNAi technology could reduce a patient's lp(a) levels by 98% at a high dose. Get the Inside Access Trad...
February 9, 2022, 3:35 pm
Silence therapeutics posts first human data for cardiovascular candidate
Silence Therapeutics plc SLN showed that its RNAi technology could reduce a patient's lp(a) levels by 98% at a high dose. Get the Inside Access Trad...
February 9, 2022, 3:35 pm
Heartflow, longview acquisition spac deal called off
HeartFlow Holding Inc and a special purpose acquisition company, Longview Acquisition Corp II (NYSE: LGV), have called off merger plans that woul...
February 7, 2022, 6:00 am
Heartflow, longview acquisition spac deal called off
HeartFlow Holding Inc and a special purpose acquisition company, Longview Acquisition Corp II (NYSE: LGV), have called off merger plans that woul...
February 7, 2022, 6:00 am
Heartflow, longview acquisition spac deal called off
HeartFlow Holding Inc and a special purpose acquisition company, Longview Acquisition Corp II (NYSE: LGV), have called off merger plans that woul...
February 7, 2022, 6:00 am
cardinal health: call the doctor, share buybacks have me swooning
cardinal Health: Call The Doctor, Share Buybacks Have Me Swooning...
February 7, 2022, 3:06 am